Open Internships

Overview

The Herbold Computational Biology Program of the Fred Hutchinson Cancer Center in Seattle, Washington invites applications for the Mahan postdoctoral fellowship. The fellowship will provide an exceptional individual with an early start on their career as an independent scientist by providing a 21-month stipend to pursue their proposed research project in the laboratory of a Fred Hutch Computational Biologist mentor.

Faculty of any discipline or rank from the Fred Hutch, UW, or any other institute may be proposed as co-mentors. The project must be focused on a topic of biological interest, must involve a computational or mathematical component, and may include an experimental component. A laboratory trained scientist may satisfy the computational and mathematical requirement by including a training component in their proposal. Computationally strong candidates may include a laboratory training component as well. The research direction should reflect the interests and ideas of the applicant, although the final research proposal may be jointly designed; see Additional Information for more details on the application process and for a list of potential mentors.

Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures for the world’s deadliest diseases and make life beyond cancer a reality.

At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion. 

Please direct all questions to Ruby Mae San Pedro, Computational Biology Research Administrator. 

For the Pediatric Blood and Marrow Transplantation (BMT)/Immunotherapy fellowship, the Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Pediatrics, Division of Hematology Oncology are jointly recruiting a full-time advanced fellow at the Research Associate/Acting Instructor (Provisional) level. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.

The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in BMT and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, the UW and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.

The selected individual for the advertised position is expected to participate in a year-long fellowship program with the goal of becoming an expert in BMT and Immunotherapy. This position will rotate through outpatient Hematopoietic Cell Transplantation (HCT) services (autologous and allogeneic transplant, immunotherapy, Long Term Follow Up) and on the inpatient transplant service initially as a primary care provider with increasing levels of independent patient care responsibility over the course of the year.  Exposure to some of our unique clinical programs, including non-malignant transplantation, high risk leukemia, and survivorship, will be part of the learning experience as well.  Approximately 75% of the year will be devoted to clinical activities with the remaining time available for the opportunity to participate in clinically focused research projects, which will be determined based on identification of mentors and projects. University of Washington faculty engage in teaching, research and service.

Anticipated start date: July 1, 2023